| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.31 | 0.03 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |